Cognitive decline in Parkinson disease D Aarsland, B Creese, M Politis, KR Chaudhuri, DH Ffytche, D Weintraub, ... Nature Reviews Neurology 13 (4), 217-231, 2017 | 1009 | 2017 |
Parkinson's disease symptoms: the patient's perspective M Politis, K Wu, S Molloy, P G. Bain, KR Chaudhuri, P Piccini Movement Disorders 25 (11), 1646-1651, 2010 | 649 | 2010 |
Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports Z Kefalopoulou, M Politis, P Piccini, N Mencacci, K Bhatia, M Jahanshahi, ... JAMA neurology 71 (1), 83-87, 2014 | 365 | 2014 |
Serotonergic neurons mediate dyskinesia side effects in Parkinson’s patients with neural transplants M Politis, K Wu, C Loane, NP Quinn, DJ Brooks, S Rehncrona, ... Science translational medicine 2 (38), 38ra46-38ra46, 2010 | 348 | 2010 |
The psychosis spectrum in Parkinson disease DH Ffytche, B Creese, M Politis, KR Chaudhuri, D Weintraub, C Ballard, ... Nature Reviews Neurology 13 (2), 81-95, 2017 | 334 | 2017 |
Serotonin in Parkinson's disease M Politis, F Niccolini Behavioural brain research 277, 136-145, 2015 | 321 | 2015 |
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours SS O’Sullivan, K Wu, M Politis, AD Lawrence, AH Evans, SK Bose, ... Brain 134 (4), 969-978, 2011 | 294 | 2011 |
Neuroimaging in Parkinson disease: from research setting to clinical practice M Politis Nature Reviews Neurology 10 (12), 708-722, 2014 | 292 | 2014 |
Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment A Chandra, G Dervenoulas, M Politis, ... Journal of neurology 266, 1293-1302, 2019 | 281 | 2019 |
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study M Politis, K Wu, C Loane, L Kiferle, S Molloy, DJ Brooks, P Piccini Neurobiology of disease 40 (1), 216-221, 2010 | 271 | 2010 |
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients M Politis, K Wu, C Loane, DJ Brooks, L Kiferle, FE Turkheimer, P Bain, ... The Journal of clinical investigation 124 (3), 1340-1349, 2014 | 266 | 2014 |
Buspirone: what is it all about? C Loane, M Politis Brain research 1461, 111-118, 2012 | 251 | 2012 |
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures M Politis, K Wu, C Loane, FE Turkheimer, S Molloy, DJ Brooks, P Piccini Neurology 75 (21), 1920-1927, 2010 | 244 | 2010 |
Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study M Politis, N Pavese, YF Tai, L Kiferle, SL Mason, DJ Brooks, SJ Tabrizi, ... Human brain mapping 32 (2), 258-270, 2011 | 238 | 2011 |
Clinical application of stem cell therapy in Parkinson's disease M Politis, O Lindvall BMC medicine 10, 1-7, 2012 | 220 | 2012 |
Imaging in Parkinson’s disease G Pagano, F Niccolini, M Politis Clinical Medicine 16 (4), 371, 2016 | 217 | 2016 |
Diabetes mellitus and Parkinson disease G Pagano, S Polychronis, H Wilson, B Giordano, N Ferrara, F Niccolini, ... Neurology 90 (19), e1654-e1662, 2018 | 212 | 2018 |
Advances in MRI methodology T Yousaf, G Dervenoulas, M Politis International review of neurobiology 141, 31-76, 2018 | 209 | 2018 |
Graft‐induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio M Politis, WH Oertel, K Wu, NP Quinn, O Pogarell, DJ Brooks, A Bjorklund, ... Movement Disorders 26 (11), 1997-2003, 2011 | 207 | 2011 |
Hypothalamic involvement in Huntington's disease: an in vivo PET study M Politis, N Pavese, YF Tai, SJ Tabrizi, RA Barker, P Piccini Brain 131 (11), 2860-2869, 2008 | 202 | 2008 |